Anesthesia News

Anesthesia

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Serebrovskaya EO et al. - Antibody-photosensitizer chemical conjugates are used successfully to kill cancer cells in photodynamic therapy. 4D5scFv-KillerRed showed fine targeting properties and efficiently killed p185HER-2-ECD-expressing cancer cells upon light irradiation. It also showed a remarkable additive effect with the commonly used antitumor agent cisplatin, further demonstrating the potential of the approach.

Today in Adverse Effects/Events...keeping you current

Physiology and pharmacology of nausea and vomiting
Anaesthesia & intensive care medicine, 12/01/09

Innate immunity, coagulation and placenta-related adverse pregnancy outcomes
Thrombosis Research, 11/30/09

Airway Injury During Emergency Transcutaneous Airway Access: A Comparison at Cricothyroid and Tracheal Sites
Anesthesia & Analgesia, 11/24/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address